Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-03-005893
Filing Date
2003-04-15
Accepted
2003-04-15 17:27:47
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c75799e10vk.txt 10-K 289846
3 SUBSIDIARIES OF THE REGISTRANT c75799exv21.txt EX-21 1085
4 CONSENT OF ERNST & YOUNG LLP c75799exv23w1.txt EX-23.1 1205
5 CERTIFICATION OF PRESIDENT/CHIEF EXECUTIVE OFFICER c75799exv99w1.txt EX-99.1 1754
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER c75799exv99w2.txt EX-99.2 59
  Complete submission text file 0000950134-03-005893.txt   296095
Mailing Address 425 WOODSMILL RD ST LOUIS MO 63017
Business Address 425 WOODSMILL RD ST LOUIS MO 63017 3145799899
SHEFFIELD PHARMACEUTICALS INC (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12584 | Film No.: 03651389
SIC: 2834 Pharmaceutical Preparations